The purpose of this agreement is for optimization of pathogen agnostic platform to accelerate the delivery of medical countermeasures to the warfighter.
Other Transaction IDV Awarded Last action
- Contract number
- W911SR2590004
- Awardee
-
Autonomous Therapeutics Inc. UEI JFHPX6TUYMU8
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Task orders
- 0
Award facts
- Last date to order
- Not on record
- IDV ceiling
- $40,361,551.00
- Contracting staff
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- Not on record
- Competition
- Competed Broad Agency Announcement
- Pricing
- Other
Award details come from SAM.gov/FPDS.
About this IDV
The Joint PEO Chemical and Biological Defense awarded an Other Transaction IDV to Autonomous Therapeutics Inc. with a ceiling of $40,361,551 on December 20, 2024, to optimize a pathogen-agnostic platform for accelerating delivery of medical countermeasures to the warfighter. Operating outside the FAR, the OT IDV supports development and deployment of advanced therapeutic technologies capable of responding to multiple infectious threats across defense applications. Autonomous Therapeutics, a biotechnology company based in Silver Spring, Maryland, brings specialized capability in RNA-based antiviral therapeutics and rapid-response platform development, with prior federal experience through SBIR Phase II awards and multiple research grants focused on broad-spectrum antiviral innovation.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $2,928,121 | |
| Funding Only Action | $2,474,591 | |
| Funding Only Action | $2,159,000 | |
| Funding Only Action | $6,817,000 | |
| Funding Only Action | $860,000 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $173,731 | |
| Funding Only Action | $3,610,759 | |
| Funding Only Action | $2,116,000 | |
| Original award | $3,099,000 |
Show all 11
Quick answers
Who was awarded contract W911SR2590004?
W911SR2590004 was awarded to Autonomous Therapeutics Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on December 20, 2024.
How much is contract W911SR2590004 worth?
W911SR2590004's own ceiling is $40,361,551.
Which agency awarded contract W911SR2590004?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911SR2590004, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911SR2590004 competed?
The extent of competition for W911SR2590004 was competed.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV